Suppr超能文献

用于缓慢代谢化合物清除率外推的原代人肝细胞球状体的多孔阵列培养

Multi-Well Array Culture of Primary Human Hepatocyte Spheroids for Clearance Extrapolation of Slowly Metabolized Compounds.

作者信息

Preiss Lena C, Lauschke Volker M, Georgi Katrin, Petersson Carl

机构信息

Department of Drug Metabolism and Pharmacokinetics (DMPK), The Healthcare Business of Merck KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany.

Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.

出版信息

AAPS J. 2022 Mar 11;24(2):41. doi: 10.1208/s12248-022-00689-y.

Abstract

Accurate prediction of human pharmacokinetics using in vitro tools is an important task during drug development. Albeit, currently used in vitro systems for clearance extrapolation such as microsomes and primary human hepatocytes in suspension culture show reproducible turnover, the utility of these systems is limited by a rapid decline of activity of drug metabolizing enzymes. In this study, a multi-well array culture of primary human hepatocyte spheroids was compared to suspension and single spheroid cultures from the same donor. Multi-well spheroids remained viable and functional over the incubation time of 3 days, showing physiological excretion of albumin and α-AGP. Their metabolic activity was similar compared to suspension and single spheroid cultures. This physiological activity, the high cell concentration, and the prolonged incubation time resulted in significant turnover of all tested low clearance compounds (n = 8). In stark contrast, only one or none of the compounds showed significant turnover when single spheroid or suspension cultures were used. Using multi-well spheroids and a regression offset approach (log(CL) = 1.1 × + 0.85), clearance was predicted within 3-fold for 93% (13/14) of the tested compounds. Thus, multi-well spheroids represent a novel and valuable addition to the ADME in vitro tool kit for the determination of low clearance and overall clearance prediction. Graphical Abstract.

摘要

在药物研发过程中,使用体外工具准确预测人体药代动力学是一项重要任务。尽管目前用于清除率外推的体外系统,如微粒体和悬浮培养的原代人肝细胞,显示出可重复的周转率,但这些系统的效用受到药物代谢酶活性快速下降的限制。在本研究中,将原代人肝细胞球体的多孔阵列培养与来自同一供体的悬浮培养和单个球体培养进行了比较。多孔球体在3天的孵育时间内保持存活和功能,显示出白蛋白和α-AGP的生理性排泄。与悬浮培养和单个球体培养相比,它们的代谢活性相似。这种生理活性、高细胞浓度和延长的孵育时间导致所有测试的低清除率化合物(n = 8)有显著的周转率。与之形成鲜明对比的是,当使用单个球体或悬浮培养时,只有一种或没有化合物显示出显著的周转率。使用多孔球体和回归偏移方法(log(CL) = 1.1 × + 0.85),93%(13/14)的测试化合物的清除率预测在3倍以内。因此,多孔球体是ADME体外工具包中用于测定低清除率和总体清除率预测的一种新颖且有价值的补充。图形摘要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验